227 related articles for article (PubMed ID: 12135541)
1. The GABAergic system in schizophrenia.
Blum BP; Mann JJ
Int J Neuropsychopharmacol; 2002 Jun; 5(2):159-79. PubMed ID: 12135541
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity.
Reynolds GP; Zhang ZJ; Beasley CL
Brain Res Bull; 2001 Jul; 55(5):579-84. PubMed ID: 11576754
[TBL] [Abstract][Full Text] [Related]
3. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
[TBL] [Abstract][Full Text] [Related]
4. Gestational changes of GABA levels and GABA binding in the human uterus.
Erdö SL; Villányi P; László A
Life Sci; 1989; 44(26):2009-14. PubMed ID: 2545985
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
6. Human breast cancer metastases to the brain display GABAergic properties in the neural niche.
Neman J; Termini J; Wilczynski S; Vaidehi N; Choy C; Kowolik CM; Li H; Hambrecht AC; Roberts E; Jandial R
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):984-9. PubMed ID: 24395782
[TBL] [Abstract][Full Text] [Related]
7. Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia.
Purves-Tyson TD; Brown AM; Weissleder C; Rothmond DA; Shannon Weickert C
Mol Brain; 2021 Jun; 14(1):96. PubMed ID: 34174930
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of γ-aminobutyric acid (GABA) transaminase activity contributes to GABA increase in the cerebral cortex of mice exposed to β-cypermethrin.
Han Y; Cao D; Li X; Zhang R; Yu F; Ren Y; An L
Hum Exp Toxicol; 2014 Mar; 33(3):317-24. PubMed ID: 24220872
[TBL] [Abstract][Full Text] [Related]
9. Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.
Renard J; Szkudlarek HJ; Kramar CP; Jobson CEL; Moura K; Rushlow WJ; Laviolette SR
Sci Rep; 2017 Sep; 7(1):11420. PubMed ID: 28900286
[TBL] [Abstract][Full Text] [Related]
10. Characteristic expressions of GABA receptors and GABA producing/transporting molecules in rat kidney.
Takano K; Yatabe MS; Abe A; Suzuki Y; Sanada H; Watanabe T; Kimura J; Yatabe J
PLoS One; 2014; 9(9):e105835. PubMed ID: 25188493
[TBL] [Abstract][Full Text] [Related]
11. Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia.
Rocco BR; Lewis DA; Fish KN
Biol Psychiatry; 2016 Jun; 79(12):1006-15. PubMed ID: 26364548
[TBL] [Abstract][Full Text] [Related]
12. Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.
Georgiev D; Yoshihara T; Kawabata R; Matsubara T; Tsubomoto M; Minabe Y; Lewis DA; Hashimoto T
Schizophr Bull; 2016 Jul; 42(4):992-1002. PubMed ID: 26980143
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic GABAergic system of adrenal chromaffin cells.
Kataoka Y; Gutman Y; Guidotti A; Panula P; Wroblewski J; Cosenza-Murphy D; Wu JY; Costa E
Proc Natl Acad Sci U S A; 1984 May; 81(10):3218-22. PubMed ID: 6328506
[TBL] [Abstract][Full Text] [Related]
14. In vitro and whole animal evidence that methylmercury disrupts GABAergic systems in discrete brain regions in captive mink.
Basu N; Scheuhammer AM; Rouvinen-Watt K; Evans RD; Trudeau VL; Chan LH
Comp Biochem Physiol C Toxicol Pharmacol; 2010 Apr; 151(3):379-85. PubMed ID: 20060493
[TBL] [Abstract][Full Text] [Related]
15. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
Gluck MR; Thomas RG; Davis KL; Haroutunian V
Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
McKenna KF; McManus DJ; Baker GB; Coutts RT
J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
[TBL] [Abstract][Full Text] [Related]
17. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
Xu MY; Wong AHC
Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
[TBL] [Abstract][Full Text] [Related]
18. Effects of basic fibroblast growth factor on the development of GABAergic neurons in culture.
Deloulme JC; Gensburger C; Sarhan S; Seiler N; Sensenbrenner M
Neuroscience; 1991; 42(2):561-8. PubMed ID: 1716750
[TBL] [Abstract][Full Text] [Related]
19. [Implications of GABAergic synapses in neuropsychiatry].
Lloyd KG; Perrault G; Zivkovic B
J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
[TBL] [Abstract][Full Text] [Related]
20. Identification of gamma-aminobutyric acid and its binding sites in Caenorhabditis elegans.
Schaeffer JM; Bergstrom AR
Life Sci; 1988; 43(21):1701-6. PubMed ID: 2848169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
